Items tagged with Latent TB
Latent TB tied to increased diabetes risk (post)
A study published in Diabetes Care suggested that people with latent TB infection are at increased risk of developing diabetes.
UC research shows people with latent TB infection are more prone to inflammation (post)
Newly published research from the University of Cincinnati finds that people with latent tuberculosis infection (LTBI) have more inflammation and could be at a higher risk for cardiovascular disease.
Rifamycin Drug-Drug Interactions: A Guide for Primary Care Providers Treating Latent Tuberculosis Infection (post)
Rifamycin Drug-Drug Interactions: A Guide for Primary Care Providers Treating Latent Tuberculosis Infection was created through a collaboration of the State of California Department of Public Health, Tuberculosis Control Branch (CDPH), the Rutgers Ernest Mario School of Pharmacy (EMSOP), the Rutgers Global Tuberculosis Institute (GTBI), and the Curry International Tuberculosis Center (CITC).
Weekly rifapentine plus isoniazid for 3 months is safe for latent TB infection (post)
In those talking 3HP for LTBI, female sex, an age from 45 to 54 years, and use of concomitant medications were significantly linked to SDRs and discontinuing treatment.
Screen for latent TB infection, USPSTF says (post)
The U.S. Preventive Services Task Force (USPSTF) said adults at increased risk for tuberculosis (TB) should still be screened for latent tuberculosis infection (LTBI).
Latent TB infection remains a public health threat in Bangladesh (post)
Experts emphasize that raising awareness and promoting a healthy lifestyle can significantly reduce the risk of latent tuberculosis infection (LTBI), which continues to pose a major public health threat in Bangladesh.
Earlier antiretroviral treatment has led to a major decline in TB among people with HIV in Switzerland (post)
Rising CD4 counts and suppressed viral load on antiretroviral treatment have had a far greater impact on reducing new cases of tuberculosis (TB) in people with HIV in Switzerland than testing and preventive treatment for latent TB, researchers from the Swiss HIV Cohort report in the journal Clinical Infectious Diseases.
India includes first skin test for latent TB diagnostics into national program (post)
The National Tuberculosis Elimination Programme (NTEP) has included Serum-Mylab’s indigenously developed latent test to detect tuberculosis to further its effort to eliminate the infectious disease by 2025.
HIV virologic suppression maintained during latent TB treatment (post)
Virologic suppression can be maintained among patients with HIV infection receiving integrase strand transfer inhibitor (INSTI)-containing antiretroviral therapy (ART) in combination with short-course rifapentine-based regimens for latent tuberculosis (TB) management, according to study results published in Clinical Infectious Diseases.
TB testing practices may miss high-risk groups (post)
Key takeaways:
Page 11 of 13 · Total posts: 0
←First 10 11 12 Last→